Martin Marietta Materials (MLM)
NYSEMaterialsConstruction MaterialsSnapshot 2026-09-04
NYSEMaterialsConstruction MaterialsSnapshot 2026-09-04
Research Workspace
Put MLM beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Materials: fringe margins under pressure (0q confirmed)
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisRevenue growth is slowing — up about 3% over the past year and decelerating.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationModerate volatility — typically moves about 2% a day.
View RiskMartin Marietta Materials must keep growing to justify its current price. The company’s recent revenue growth is steady, with a 21% year-over-year increase. It beat earnings expectations last quarter, reporting an EPS of 5.0. The stock trades at 28× P/E, above the 18× peer median. This suggests the price reflects less growth than expected. If MLM cuts guidance on the next call, that could hurt the stock. Peer multiples imply a price about 13% below where it trades. This read is provisional.
Trailing returns as of 2026-09-04. MLM is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 25 analysts currently covering MLM (as of Sep 2026).
Based on 9 Wall Street analysts offering 12-month price targets for MLM in the last 4 months.
Continue this research
Compare MLM with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| MLM Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 12 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Construction Materials — fair value, gap to price, and forward P/E.
Compare the value case
Put MLM next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Execute portfolio optimization through acquisitions and divestitures
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-04. EPS is implied from price ÷ P/E. Not investment advice.
Current $514.77
The last 12 months of price, then the range of analyst 12-month targets from today’s $514.77.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Upgrade indicates confidence in acquisition synergies.

Threatens: Execute portfolio optimization through acquisitions and divestitures
Lhoist deal may hinder portfolio optimization efforts.

Advances: Manage capital expenditures within $550-$600 million range
Dividend increase signals strong cash flow management.

Advances: Manage capital expenditures within $550-$600 million range
Funding for capital expenditures aligns with management's objectives.

Advances: Execute portfolio optimization through acquisitions and divestitures
Guidance raised indicates effective portfolio optimization and cost management.

Acquisition aligns with growth strategy and enhances market position.
Advances: Reaffirm 2026 Adjusted EBITDA guidance
Earnings beat and positive outlook support EBITDA guidance.
